Stark Wipes Out $235M Infringement Verdict Against Teva for Hypertension Drug | Delaware Business Court Insider
Teva, one of the biggest generic makers, joins the the brand-name club
An Israeli pharma champion sickens | The Economist
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval for Migraine Therapy - Warrior Trading News
Israeli pharmaceutical giant's bid for rival a hard pill to swallow - Washington Jewish Week
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Israel's Teva gives upbeat outlook as restructuring proceeds | The Seattle Times
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel
Teva CEO stands down during troubled times - MedCity News
Pharma giant Teva looks to steady ship with new CEO in coming weeks | The Times of Israel
Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone | Fierce Pharma
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Israel targets Teva over MS drug royalties
FDA Nod to New MS Drug Spells Trouble for Teva - Haaretz Com - Haaretz.com
Teva Pharmaceuticals - Wikiwand
Israeli authorities cut Teva some slack as foreign bribery case resolved amid other big problems | Fierce Pharma
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva Pharmaceutical Set for Major Layoffs in Israel, U.S.: Report
Teva to cut 14,000 jobs | Business | Chemistry World
Teva Pharmaceuticals - Wikipedia
Teva Pharma Plunges After Two U.S. Copaxone Patents Invalidated | Investor's Business Daily
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Analysts Split Over Buffett's Backing of Teva Pharma | BioSpace
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
